Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01350349 · ClinicalTrials.gov registry record · NA

Home-delivered Intervention for Depressed, Cognitively Impaired Elders

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
134
Enrollment target

NCT01350349 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 134 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01350349, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target

Study Summary

Among older adults the combination of depression, cognitive impairment (memory problems), and disability contribute to a worsening of physical and mental health and to poor treatment outcomes. Antidepressants help fewer than 40% of depressed elders with memory problems achieve remission from their depression. Interventions involving talking therapy are underdeveloped and understudied. Therefore, this research study will test the efficacy of Problem Adaptation Therapy (PATH), a new home-delivered psychosocial intervention for elders with major depression, memory problems, and disability. PATH focuses on the subject's "ecosystem" (the patient, the caregiver, and the home-environment) and targets behavioral problems related to both depression and disability. PATH is delivered in a subject's home, where cognitively impaired, disabled elders face most of their difficulties. Local Home Delivered Meals programs will refer clients who have symptoms of depression and are interested in research. All participants will have an available caregiver (family, significant other, or professional) and will be randomized to 12 weekly sessions of PATH or Supportive Therapy, the current standard of care for talking therapy. The study will test whether home-delivered PATH is more effective than home-delivered Supportive Therapy in reducing the subjects' depression and disability and in increasing self-efficacy over the 12-week treatment period.

Interventions

  • BEHAVIORAL Supportive Therapy
  • BEHAVIORAL Problem Adaptation Therapy (PATH)

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2011-04
Est. Completion 2017-02
Phase NA

What the Registry Record Tells You About NCT01350349

The ClinicalTrials.gov registry entry for NCT01350349 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy is the first listed.

NCT01350349 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01350349 about?

NCT01350349 is a clinical study titled "Home-delivered Intervention for Depressed, Cognitively Impaired Elders". Among older adults the combination of depression, cognitive impairment (memory problems), and disability contribute to a worsening of physical and mental health and to poor treatment outcomes. Antidepressants help fewer than 40% of depressed elders with memory problems achieve remission from their d...

What is the current status of trial NCT01350349?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2011-04. Estimated completion is 2017-02.

What interventions are being tested in trial NCT01350349?

The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Problem Adaptation Therapy (PATH) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01350349?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.